DXB presenting at a US biotech conference in California.

Investment Memo: DXB 2022

General: Investor Presentation

This morning our 2021 Biotech Pick of the Year, Dimerix Ltd (ASX: DXB) put out an updated investor presentation and confirmed that CEO & Managing Director, Dr Nina Webster, will be presenting at the BIO International Convention in California.

BIO, who is running the conference, is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organisations across the United States and in 30+ countries.

The convention in the US attracts more than 15,000 biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships.

We are hoping the presentations will put DXB on the radar of US investors who might be interested in the DXB’s Phase 3 FSGS trials.